ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,793,412 | +8.0% | 87,527 | +4.7% | 0.00% | 0.0% |
Q2 2023 | $1,660,357 | +104985.9% | 83,561 | -9.4% | 0.00% | 0.0% |
Q1 2023 | $1,580 | -5.2% | 92,222 | +8.3% | 0.00% | 0.0% |
Q4 2022 | $1,667 | -99.9% | 85,192 | +21.3% | 0.00% | 0.0% |
Q3 2022 | $1,121,000 | +22.9% | 70,256 | +6.0% | 0.00% | +100.0% |
Q2 2022 | $912,000 | +28.8% | 66,295 | +48.5% | 0.00% | 0.0% |
Q1 2022 | $708,000 | -24.7% | 44,652 | +3.7% | 0.00% | 0.0% |
Q4 2021 | $940,000 | -29.2% | 43,077 | -3.0% | 0.00% | -50.0% |
Q3 2021 | $1,327,000 | -29.8% | 44,396 | +4.0% | 0.00% | 0.0% |
Q2 2021 | $1,890,000 | -0.8% | 42,684 | -0.6% | 0.00% | -33.3% |
Q1 2021 | $1,905,000 | -24.4% | 42,939 | -6.5% | 0.00% | 0.0% |
Q4 2020 | $2,519,000 | +142.0% | 45,940 | +0.9% | 0.00% | +50.0% |
Q3 2020 | $1,041,000 | -3.4% | 45,533 | -11.6% | 0.00% | 0.0% |
Q2 2020 | $1,078,000 | +96.0% | 51,483 | +30.5% | 0.00% | +100.0% |
Q1 2020 | $550,000 | -35.5% | 39,442 | +5.2% | 0.00% | 0.0% |
Q4 2019 | $853,000 | +98.8% | 37,493 | +1.8% | 0.00% | 0.0% |
Q3 2019 | $429,000 | -22.6% | 36,823 | -0.4% | 0.00% | 0.0% |
Q2 2019 | $554,000 | +3.0% | 36,963 | +20.4% | 0.00% | 0.0% |
Q1 2019 | $538,000 | +29.0% | 30,695 | +9.1% | 0.00% | 0.0% |
Q4 2018 | $417,000 | -11.3% | 28,122 | +47.3% | 0.00% | 0.0% |
Q3 2018 | $470,000 | +18.1% | 19,086 | -5.9% | 0.00% | 0.0% |
Q2 2018 | $398,000 | – | 20,287 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |